Better Recovery Story Buy: Teladoc vs. Novavax
The bear market weighed on stocks in general this year. Even some of the healthiest companies. But some stocks actually fell for a particular reason: They disappointed investors. They've dropped to bargain prices, but certain players may not stay at these levels for long.
Teladoc Health (NYSE: TDOC) and Novavax (NASDAQ: NVAX) are among the stocks that crashed this year. They're each heading for annual losses of more than 70%. Both of these healthcare stocks represent potential recovery stories. But which one is a better buy now? Let's find out.
Investors didn't like Teladoc's news earlier this year. The telemedicine leader reported two billion-dollar goodwill impairment charges. They were linked to the 2020 purchase of chronic care specialist Livongo. This indicates Teladoc paid too much for the company.
Source Fool.com
